Stretta radiofrequency treatment for GERD: A safe and effective modality

American Journal of Gastroenterology

Volumn 108, Issue 10, 2013, Pages 1654-1655

  Franciosa, Mark ^a   Mashimo, Hiroshi ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR;

ENDOSCOPIC THERAPY; ESOPHAGEAL PH MONITORING; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; LETTER; LOWER ESOPHAGUS SPHINCTER; MINIMALLY INVASIVE PROCEDURE; MORBIDITY; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; RADIOFREQUENCY; SCORING SYSTEM; STOMACH PARESIS; STRETTA PROCEDURE; TREATMENT OUTCOME;

GASTROESOPHAGEAL REFLUX; HISTAMINE ANTAGONISTS; HUMANS; PROTON PUMP INHIBITORS;

EID: 84885463278     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2013.275     Document Type: Letter

References (10)

1. Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal refl ux disease. Am J Gastroenterol 2013; 108: 308-28.
2. Arts J, Sifrim D, Rutgeerts P et al. Infl uence of radiofrequency energy delivery at the gastroesophageal junction (the Stretta procedure) on symptoms, acid exposure, and esophageal sensitivity to acid perfusion in gastroeso phageal refl ux disease. Dig Dis Sci 2007; 52: 2170-7.
3. Aziz AM, El-Khayat HR, Sadek A et al. A prospective randomized trial of sham, single-dose Stretta, and double-dose Stretta for the treatment of gastroesophageal refl ux disease. Surg Endosc 2010; 24: 818-25.
4. Perry KA, Banerjee A, Melvin WS. Radiofrequency energy delivery to the lower esophageal sphincter reduces esophageal acid exposure and improves GERD symptoms: A systematic review and meta-analysis. Surg Laparosc Endosc Percutan Tech 2012; 22: 283-8.
5. Hershcovici T, Mashimo H, Fass R. The lower esophageal sphincter. Neurogastroenterol Motil 2011; 23: 819-30.
6. Triadafilopoulos G, DiBaise JK, Nostrant TT et al. The Stretta procedure for the treatment of GERD: 6 and 12 month follow-up of the U.S. open label trial. Gastrointest Endosc 2002; 55: 149-56.
7. Liu HF, Zhang JG, Li J et al. Improvement of clinical parameters in patients with gastroesophageal refl ux disease aft er radio frequency energy delivery. World J Gastroenterol 2011; 17: 4429.
8. Dughera L, Navino M, Cassolino P et al. Long-term results of radiofrequency energy delivery for the treatment of GERD: Results of a prospective 48-month study. Diagn Ther Endosc 2011; 507: 157.
9. Urbach DR, Horvath KD, Baxter NN et al. A research agenda for gastrointestinal and endoscopic surgery. Surg Endosc 2007; 21: 1518-25.
10. Auyang ED, Carter P, Rauth T et al. SAGES clinical spotlight review: Endoluminal treatments for gastroesophageal refl ux disease (GERD). Surg Endosc 2013; 27: 2658-72.